DCLK1 and cancer: All studies were retrospective, and most of studies adopted immunohistochemistry (IHC) to detect the expression of DCLK1 in cancer tissues samples that composed of malignant cell and a supporting stroma, while one adopted reverse transcription-polymerase chain reaction (RT-PCR).